Peptides bind receptors when their shape and chemistry fit a cell protein's binding site.

Peptides bind receptors when their shape and chemistry fit a cell protein's binding site. To understand how peptides bind receptors, researchers test both attachment and cell signals. These tests examine research peptides and separate a fit from its effect.

A peptide is a short chain of amino acids. A receptor is a cell protein that binds a signal and can change what the cell does.
Many peptide receptors sit in the cell membrane. A major group, called G protein-coupled receptors (GPCRs), crosses the membrane and passes signals into the cell.
GPCRs have a membrane-spanning structure with several parts that cross the cell's outer layer. These parts help form a binding site and link contact outside the cell to signal steps inside it.
Peptide signals also act through other receptor families. Some receptors have built-in enzyme activity, while others control the flow of charged particles across the membrane.
Peptide- and protein-activated receptors account for about 46% of all class A GPCRs in humans, according to a review in Molecules. Class A is one large group of GPCRs, so this figure describes peptide sensing within that group.
These different receptor types do not pass signals in the same way. Knowing which receptor family a peptide binds helps researchers choose tests that can measure the right signal route.
A receptor's binding site is the part that contacts a peptide. Matching shape and chemical features help the two fit, but the match is flexible, not a fixed lock and key.

Parts with opposite charges can attract. Compatible atoms can form hydrogen bonds, which are weak attractions between certain atoms, while water-avoiding parts can pack together.
Each contact may be weak on its own. Several contacts in the right places can add up and keep the peptide and receptor bound.
A peptide can bend as it approaches its receptor, and the receptor can shift shape as well. This flexible fit helps explain why a peptide's position, sequence, and ends can affect binding.
Researchers describe two related ways that shape changes can help binding. In conformational selection, the receptor already shifts among shapes, and the peptide favors one; in induced fit, contact with the peptide helps shift the receptor.
The peptide's direction also matters. Its two ends and the positions of its amino acids can make different contacts with parts of the receptor, changing how well the pair fits.
A peptide ligand, meaning a peptide that binds a receptor, can vary greatly in size. A review in Molecules describes peptide ligands as ranging up to about 100 amino acids.
Binding affinity describes how readily a peptide and receptor stay bound. Researchers often report it using a measure called the dissociation constant, or Kd; a lower Kd means tighter binding in that test.
Higher affinity can mean that more receptors are occupied at a lower free peptide level. It does not show that the receptor sends a strong signal after binding.
Binding specificity describes how strongly a peptide favors one receptor over other receptors. A result for one receptor alone cannot show whether the peptide also binds other targets.
To assess selectivity, researchers compare binding or cell responses across a panel of receptor types. The choice of receptors matters because a narrow test can miss other interactions.
Changing the order of amino acids or the peptide's shape can alter binding and cell activity. Researchers call the link between a molecule's structure and its measured activity a structure-activity relationship.
A peptide may bind without switching a receptor on. Two peptides that bind the same receptor may also favor different signal routes, because each can stabilize a different receptor shape.
When a peptide binds, it may shift the receptor's shape. An agonist is a ligand that switches a receptor on, while an antagonist binds and blocks activation.

Some agonists switch a receptor on fully, while partial agonists produce a smaller response in the same test. Binding alone cannot tell which of these outcomes occurred.
Some GPCRs pass signals through proteins called G proteins. These can change the level of second messengers, small molecules inside the cell that relay a signal.
Other receptor families use different routes. Some start enzyme activity inside the cell, while others open or close a path for charged particles to cross the membrane.
These steps are part of signal transduction, the process that carries a receptor's activity into the cell. A test of one step, such as a change in a second messenger, does not describe every later cell response.
A peptide can also bind an allosteric site, a spot apart from the main binding site. Contact there can change how the receptor responds to another ligand, without occupying the main site.
The same peptide can lead to different results in different cell types. Those cells may have different numbers of the receptor or different proteins that carry signals onward.
Cells can also vary in how they handle a signal after it begins. Different enzymes, signal proteins, or feedback steps can change the size and length of the measured response.
Most peptide-receptor binding takes place at the cell surface. Some peptides can enter cells and bind targets inside them, but surface binding alone does not show that entry occurred.
In receptor-mediated internalisation, a cell moves a receptor and its bound peptide inward. This process differs from a peptide crossing the membrane on its own.
The cell response can depend on how many receptors are occupied and which signal routes are active. A report of binding, by itself, does not show the full response of a cell.
A direct-binding test asks whether a peptide attaches to a receptor. One method tracks a labelled peptide; another measures whether the peptide competes with a second ligand for binding.

Competition tests can show that two ligands affect access to a receptor. They do not, by themselves, show that the ligands make the same contacts or bind in exactly the same place.
A cell-response test measures what happens after cells encounter a peptide. It might track a second messenger, a change in cell activity, or the movement of a receptor.
A cell response does not alone prove direct binding to the proposed receptor. Researchers can compare responses across receptor types, then test whether the signal changes when a receptor is altered or absent.
Researchers can also alter parts of a peptide or receptor to see which parts matter. A change in binding can point to a useful contact, but it does not prove the full route from binding to cell response.
Tests of internalisation track whether a receptor or peptide moves into cells. A strong account of a mechanism brings together evidence for attachment, receptor activity, and the measured cell response.
How peptides bind receptors depends on shape, chemical contacts, and the changing forms of both partners. But binding strength does not tell the whole story: receptor type, cell context, and signal routes also shape the result.
For research peptides, direct-binding tests and cell-response tests provide different evidence. Comparing both helps show whether a peptide attaches to a receptor, what the receptor does next, and which cell signals follow.